USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-03-12 обновлены отчеты компании HRTX: 20232022
Heron Therapeutics logo
Heron Therapeutics HRTX
$ 2.51 7.05%

Heron Therapeutics Мультипликаторы 2011-2024 | HRTX

Мультипликаторы по годам Heron Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-2.9 -1.1 -0.0 -6.9 -8.6 -11.0 -6.3 -2.7 -7.1 -2.7 -3.5 -8.3 -2.9

P/S

2.6 1.9 0.0 17.8 12.0 25.5 40.1 372.1 - - - - 52.1

EPS

-0.8 -1.7 -2.2 -2.5 -2.5 -2.4 -3.6 -4.6 -3.0 -2.9 -3.4 -1.9 -2.0

EV (Enterprise Value)

554 млн 428 млн 138 млн 1.59 млрд 1.79 млрд 2.03 млрд 1.19 млрд 551 млн 639 млн 151 млн 126 млн 144 млн 19.4 млн

EBITDA per Share

-0.78 -1.58 -2.18 тыс. -2.48 -2.55 -2.49 -3.57 -4.48 -2.91 -2.78 -3.35 -1.93 -1.81

EV/EBITDA

-4.3 -6.6 -8.1 -10.7 -5.8 -3.0 -6.5 -1.9 -2.2 -5.9 -1.5

PEG

-0.0 -0.0 -0.0 3.07 -3.48 0.33 0.31 -0.05 -2.55 0.17 -0.05 0.49 0.06

P/B

-9.6 15.2 0.0 6.7 4.3 5.3 9.4 -22.4 5.9 3.3 2.8 3.7 2.1

P/CF

-5.5 -1.4 -0.0 -8.2 -13.3 -9.8 -7.1 -3.5 -8.7 -3.4 -4.5 -10.7 -4.1

ROE %

325.43 -1341.17 -284.50 -96.10 -50.70 -48.31 -150.59 814.75 -82.63 -121.10 -80.18 -45.06 -75.00

ROA %

-49.69 -72.53 -72.19 -64.28 -39.93 -38.69 -84.28 -256.58 -70.80 -99.59 -72.80 -41.71 -60.76

ROCE %

325.60 -1286.90 -280.81 -90.88 -50.64 -49.69 -148.36 -594.51 -82.06 -118.23 -78.99 -45.99 -70.23

Current Ratio

0.9 1.1 1.3 3.1 5.0 4.9 2.2 1.6 6.8 5.4 10.4 13.0 4.9

DSO

161.2 148.4 163.5 172.3 99.7 304.6 496.8 559.3 - - - - -

DIO

271.0 342.4 358.0 422.7 147.9 517.8 804.1 55688.6 - - - - -

DPO

18.1 23.4 17.2 6.3 18.2 226.7 1504.9 81895.6 - - - - -

Операционный цикл

432.2 490.8 521.5 595.0 247.6 822.4 1300.9 56247.9 - - - - -

Финансовый цикл

414.1 467.4 504.4 588.6 229.4 595.7 -204.0 -25647.7 - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Heron Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.17 -0.35 -0.27 - -0.38 -0.55 -0.63 - -0.51 -0.62 -0.58 -0.68 -0.64 -0.61 -0.57 -0.65 -0.42 -0.63 -0.8 -0.63 -0.49 -0.54 -0.81 -1.09 -0.77 -0.8 -1 -1.22 -1.24 -1.17 -0.92 -0.87 -0.63 -0.74 -0.7 -0.71 -0.66 -0.78 -0.74 -0.75 -0.84 -1.01 -0.85 -0.51 -0.45 -0.46 -0.85 -0.02 -0.02 -0.05 -0.04

EBITDA per Share

- - -0.27 - -0.36 -0.47 -0.61 - -0.49 -0.6 -0.56 -0.67 -0.62 -0.6 -0.58 -0.66 -0.42 -0.64 -0.82 -0.66 -0.52 -0.53 -0.8 - -0.74 -0.77 -0.97 - -1.2 -1.15 -0.91 - -0.61 -0.73 -0.69 - -0.64 -0.76 -0.73 - -0.81 -0.99 -0.83 - -0.02 -21.4 -0.02 - - - -

ROE %

297.10 20.43 172.65 -194.05 -238.15 -95.57 -392.97 -109.02 -135.35 -115.88 -101.11 -96.10 -84.11 -67.81 -56.91 -50.70 -49.75 -51.79 -49.80 -48.31 -82.58 -104.14 -126.34 -150.59 122.76 382.95 618.99 814.75 562.60 315.14 92.17 -82.63 -88.88 -100.12 -110.70 -121.10 -108.76 -97.00 -89.21 -80.18 -74.75 -67.89 -54.35 -60.56 -72.68 -87.54 -90.99 -75.00 -26.68 -12.27 -9.01

ROA %

-62.06 -66.56 -68.76 -61.85 -76.72 -76.19 -68.18 -46.89 -64.50 -66.10 -66.62 -64.28 -57.96 -48.05 -42.23 -39.93 -39.36 -41.10 -39.67 -38.69 -54.64 -64.21 -74.11 -84.28 -128.69 -182.71 -228.50 -256.58 -208.17 -152.73 -105.44 -70.80 -75.03 -83.61 -91.64 -99.59 -91.19 -83.11 -78.61 -72.80 -68.13 -62.11 -49.98 -56.06 -64.15 -74.83 -76.60 -60.76 -21.61 -9.94 -7.30

ROCE %

300.39 24.12 143.90 -221.47 -264.98 -121.93 -387.42 -107.83 -133.75 -114.93 -100.74 -96.48 -85.26 -69.20 -58.45 -52.17 -51.34 -53.99 -51.67 -49.69 -67.33 -87.55 -109.12 -101.17 123.45 379.58 614.30 584.03 564.99 321.32 99.18 -55.77 -85.82 -96.83 -107.14 -87.32 -105.69 -94.00 -86.26 -58.92 -70.61 -63.92 -50.31 -29.34 -55.30 -69.57 -70.90 -44.08 -25.96 -9.78 -8.35

Current Ratio

0.9 0.8 0.9 1.1 1.1 0.9 1.1 1.3 1.5 1.7 2.7 3.0 3.0 3.0 3.0 4.7 4.7 4.7 4.7 5.0 5.0 5.0 5.0 2.3 3.0 3.2 2.7 0.8 0.8 0.8 0.8 7.0 7.0 - - - - - - - - - - - - - 16.6 5.3 7.5 6.0 -

DSO

203.9 184.1 159.4 - 141.7 134.4 149.0 - 168.3 164.9 183.2 185.3 191.3 168.5 146.8 103.7 85.4 99.3 150.9 204.5 298.2 341.5 420.2 380.1 445.8 449.0 550.6 - - - - - - - - - - - - - - - - - - - - - - - -

DIO

217.1 218.8 288.7 - 352.0 332.2 421.3 - 338.9 268.4 418.9 407.1 533.3 424.6 287.2 143.5 132.5 167.7 195.2 307.8 470.1 680.9 715.6 689.4 877.6 910.5 594.3 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

9.6 13.6 19.7 - 63.1 62.1 48.3 - 68.8 40.6 11.0 5.1 6.7 5.3 14.1 15.8 14.6 18.5 59.8 133.0 203.1 294.2 518.9 1280.0 1629.6 1690.7 984.2 - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

421.0 402.9 448.1 - 493.8 466.7 570.3 - 507.2 433.4 602.1 592.5 724.6 593.1 434.1 247.2 217.9 266.9 346.1 512.3 768.3 1022.4 1135.8 1069.4 1323.3 1359.5 1144.9 - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

411.4 389.3 428.4 - 430.7 404.5 522.0 - 438.3 392.7 591.1 587.4 717.9 587.8 419.9 231.4 203.2 248.4 286.2 379.3 565.2 728.2 616.9 -210.6 -306.2 -331.2 160.8 - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD